June 3 (Reuters) - U.S. Food and Drug Administration staff
released voting questions on Teva Pharmaceutical Industries
Ltd's long-acting opioid painkiller for a panel of
independent experts who will recommend to the agency whether to
approve the drug.
Read more
No comments:
Post a Comment